49 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
property), mortgage, license, or other legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person or any
8-K
EX-10.1
COGT
Cogent Biosciences Inc
7 Jun 23
Departure of Directors or Certain Officers
4:24pm
underwritten, firm commitment public offering pursuant to an effective registration statement under the Act covering the offer and sale by the Company of its
424B5
znd hvfr53dlx9qdjotb
15 Jun 22
Prospectus supplement for primary offering
5:16pm
424B5
nix0fl kuqw
13 Jun 22
Prospectus supplement for primary offering
6:11am
8-K
EX-10.1
pctvvpk2de
17 Jun 21
Departure of Directors or Certain Officers
7:00am
424B5
feku aczg
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
bla6b8 05kkniman48e1
30 Nov 20
Prospectus supplement for primary offering
5:28pm